@aisavvycapital · Long ABSI

BIO-TECH had a strong sell off today (10% or more on many names), so I'm buying afterhours as it may bounce in morning, here are my favs: • ABSI — about $2.0B. Generative AI designs antibodies from scratch, closest to Moderna’s model. Phase 2 endometriosis trial for ABS-201 is

Read asLong ABSI+4 more

Since the call—

unrankedThe analyst's rank today

High · 0.99Confidence

Tue, Oct 6Tweeted

Wed, Oct 7 closeCounted from

4% of the basket · day 9fades out by Nov 17

Rank per close

#112

Oct 7

—

Oct 8

#143

Oct 11

#288

Oct 12

—

Oct 13

—

Oct 14

—

Oct 15